Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAB-176 in H1N1 Challenge Model
NCT04850898Phase 2Completed
- Sponsor
- SAB BIO
- Start
- Jun 2021
- Primary completion
- Oct 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of SAB-176 in Influenza A (IAV), sponsored by SAB BIO. Started Jun 2021; status: completed.
02
Drugs
SAB-176
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT04850898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04850898.